Indefinite Delivery Contract SPE2DR25D3008

The federal contract IDV award, SPE2DR25D3008, is an Indefinite Delivery Contract with a ceiling value of $999,999,999.00 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract, which runs through December 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract serves as a prime vehicle for the DLA to efficiently procure essential medical commodities for the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The original solicitation, issued by the DLA Troop Support Medical Supply Chain, aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers. The procurement, valued at an estimated $30.3 billion, will result in multiple regional awards to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The contract will have a 30-month base period with three 30-month option periods, and will be awarded on a Lowest Price Technically Acceptable basis, with the potential use of reverse auctions to determine final distribution fees.